Formulation 4 aminopyridine. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Neurons Hippocampus Muscle, Smooth, Vascular Cells, Cultured Pulmonary Stretch Receptors Neuromuscular Junction Pyramidal Cells Pulmonary Artery Heart Nerve Endings Heart Ventricles Muscle, Smooth

Organisms6

Rats, Sprague-Dawley Guinea Pigs Rats, Wistar Dogs Rabbits Animals, Newborn

Diseases2

Epilepsy Seizures

Chemicals and Drugs91

4-Aminopyridine Aminopyridines Potassium Channel Blockers Tetraethylammonium Tetraethylammonium Compounds Potassium Channels Excipients Potassium Channels, Voltage-Gated Delayed-Action Preparations Potassium Charybdotoxin Tablets Dosage Forms Delayed Rectifier Potassium Channels Drug Carriers Kv1.5 Potassium Channel Elapid Venoms Barium Compounds Neuromuscular Depolarizing Agents Apamin Barium Emulsions Tetrodotoxin Calcium Capsules Powders Cesium Glyburide Pharmaceutical Solutions Quinidine Potassium Channels, Calcium-Activated Kv1.4 Potassium Channel Methylcellulose Ion Channels Liposomes Scorpion Venoms Shaw Potassium Channels Pharmaceutical Vehicles Calcium Channel Blockers Suspensions Quinine Kv1.1 Potassium Channel Shab Potassium Channels Kv1.2 Potassium Channel Endothelium-Dependent Relaxing Factors Gels Convulsants Pyridostigmine Bromide Polysorbates Pharmaceutical Preparations Shaker Superfamily of Potassium Channels Tubocurarine Shal Potassium Channels Acetylcholine Quinoxalines Poloxamer Cromakalim Surface-Active Agents Procaine Polyglycolic Acid Cadmium Polyethylene Glycols Large-Conductance Calcium-Activated Potassium Channels Emulsifying Agents Vasodilator Agents Verapamil Potassium Channels, Tandem Pore Domain Pinacidil Nifedipine Polymyxins Polymers Calcium Channels Chitosan Potassium Chloride Preservatives, Pharmaceutical Sodium Drug Combinations Pyridines Carboxymethylcellulose Sodium Polymethacrylic Acids FMRFamide Quaternary Ammonium Compounds Nanocapsules Neurotransmitter Agents Amphotericin B Aluminum Hydroxide Carbenoxolone Excitatory Amino Acid Antagonists Oxadiazoles Bicuculline Diltiazem

Analytical, Diagnostic and Therapeutic Techniques and Equipment21

Drug Compounding Delayed-Action Preparations Dosage Forms Patch-Clamp Techniques Drug Carriers Technology, Pharmaceutical Drug Stability Drug Delivery Systems Pharmaceutical Vehicles Electric Stimulation Administration, Oral Chromatography, High Pressure Liquid Freeze Drying Administration, Topical Drug Storage Microelectrodes Administration, Cutaneous Area Under Curve Nanocapsules Cross-Over Studies Microspheres

Phenomena and Processes24

Membrane Potentials Action Potentials Electric Conductivity Therapeutic Equivalency Particle Size Biological Availability Dose-Response Relationship, Drug Solubility Skin Absorption Ion Channel Gating Time Factors Kinetics Synaptic Transmission Hydrogen-Ion Concentration Carbohydrate Sequence Vasodilation Muscle Relaxation Evoked Potentials Area Under Curve Muscle Contraction Ventricular Function Vasoconstriction Viscosity Carbohydrate Conformation

Disciplines and Occupations3

Chemistry, Pharmaceutical Electrophysiology Technology, Pharmaceutical

Technology, Industry, Agriculture10

Technology, Pharmaceutical Nanoparticles Liposomes Polysorbates Poloxamer Polyglycolic Acid Polyethylene Glycols Polymers Polymethacrylic Acids Nanocapsules

Information Science1

Carbohydrate Sequence

Health Care2

Area Under Curve Cross-Over Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

4-Aminopyridine Aminopyridines Potassium Channel Blockers Chemistry, Pharmaceutical Tetraethylammonium Tetraethylammonium Compounds Potassium Channels Membrane Potentials Drug Compounding Excipients Potassium Channels, Voltage-Gated Delayed-Action Preparations Potassium Charybdotoxin Tablets Action Potentials Dosage Forms Patch-Clamp Techniques Electrophysiology Delayed Rectifier Potassium Channels Drug Carriers Kv1.5 Potassium Channel Elapid Venoms Barium Compounds Neuromuscular Depolarizing Agents Technology, Pharmaceutical Apamin Barium Emulsions Drug Stability Tetrodotoxin Electric Conductivity Calcium Therapeutic Equivalency Capsules Particle Size Powders Biological Availability Drug Delivery Systems Cesium Dose-Response Relationship, Drug Glyburide Solubility Pharmaceutical Solutions Rats, Sprague-Dawley Guinea Pigs Rats, Wistar Quinidine Skin Absorption Potassium Channels, Calcium-Activated Nanoparticles Kv1.4 Potassium Channel Methylcellulose Ion Channels Liposomes Scorpion Venoms Shaw Potassium Channels Pharmaceutical Vehicles Electric Stimulation Calcium Channel Blockers Neurons Suspensions Ion Channel Gating Administration, Oral Quinine Chromatography, High Pressure Liquid Time Factors Hippocampus Freeze Drying Kv1.1 Potassium Channel Administration, Topical Shab Potassium Channels Kinetics Kv1.2 Potassium Channel Drug Storage Endothelium-Dependent Relaxing Factors Synaptic Transmission Gels Hydrogen-Ion Concentration Muscle, Smooth, Vascular Convulsants Pyridostigmine Bromide Polysorbates Carbohydrate Sequence Microelectrodes Dogs Pharmaceutical Preparations Rabbits Shaker Superfamily of Potassium Channels Administration, Cutaneous Tubocurarine Shal Potassium Channels Acetylcholine Vasodilation Quinoxalines Poloxamer Cells, Cultured Cromakalim Muscle Relaxation Surface-Active Agents

No FAQ available that match "formulation 4 aminopyridine"